- Home
- AUPH vs NTCT Comparison
AUPH vs NTCT Comparison
Compare AUPH & NTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- NTCT
- Stock Information
- Founded
- AUPH 1993
- NTCT 1984
- Country
- AUPH Canada
- NTCT United States
- Employees
- AUPH N/A
- NTCT N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- NTCT EDP Services
- Sector
- AUPH Health Care
- NTCT Technology
- Exchange
- AUPH Nasdaq
- NTCT Nasdaq
- Market Cap
- AUPH 1.4B
- NTCT 1.6B
- IPO Year
- AUPH 1999
- NTCT 1999
- Fundamental
- Price
- AUPH $12.22
- NTCT $22.59
- Analyst Decision
- AUPH Strong Buy
- NTCT Hold
- Analyst Count
- AUPH 4
- NTCT 1
- Target Price
- AUPH $12.25
- NTCT $25.00
- AVG Volume (30 Days)
- AUPH 2.8M
- NTCT 676.1K
- Earning Date
- AUPH 07-31-2025
- NTCT 08-07-2025
- Dividend Yield
- AUPH N/A
- NTCT N/A
- EPS Growth
- AUPH N/A
- NTCT N/A
- EPS
- AUPH 0.42
- NTCT 1.02
- Revenue
- AUPH $260,111,000.00
- NTCT $834,861,000.00
- Revenue This Year
- AUPH $12.15
- NTCT $3.89
- Revenue Next Year
- AUPH $18.34
- NTCT $2.40
- P/E Ratio
- AUPH $29.06
- NTCT $22.20
- Revenue Growth
- AUPH 25.59
- NTCT 5.29
- 52 Week Low
- AUPH $6.23
- NTCT $18.12
- 52 Week High
- AUPH $12.53
- NTCT $27.89
- Technical
- Relative Strength Index (RSI)
- AUPH 78.39
- NTCT 52.62
- Support Level
- AUPH $11.18
- NTCT $22.21
- Resistance Level
- AUPH $11.69
- NTCT $23.20
- Average True Range (ATR)
- AUPH 0.60
- NTCT 0.65
- MACD
- AUPH 0.12
- NTCT 0.18
- Stochastic Oscillator
- AUPH 91.61
- NTCT 78.29
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About NTCT NetScout Systems Inc.
NetScout Systems Inc is a provider of service assurance and cybersecurity solutions to enterprise and government networks. It bases its solutions on proprietary adaptive service intelligence technology, which helps customers monitor and identify performance issues and provides insight into network-based security threats. These solutions also deliver real-time and historical information, which provides insight to restore service and understand the quality of user experience. The company derives revenue from the sale of network management tools and security solutions. Its geographical regions include USA, which derives maximum revenue, Europe, Asia, and Rest of the World.